Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

5N2K

Structure of unbound Briakinumab FAb

Summary for 5N2K
Entry DOI10.2210/pdb5n2k/pdb
DescriptorBriakinumab FAb light chain, Briakinumab FAb heavy chain, 1,2-ETHANEDIOL, ... (6 entities in total)
Functional Keywordsantagonist, antibody, extracellular region, immune system
Biological sourceHomo sapiens (Human)
More
Total number of polymer chains16
Total formula weight453186.69
Authors
Bloch, Y.,Savvides, S.N. (deposition date: 2017-02-07, release date: 2018-01-03, Last modification date: 2024-05-01)
Primary citationBloch, Y.,Bouchareychas, L.,Merceron, R.,Skladanowska, K.,Van den Bossche, L.,Detry, S.,Govindarajan, S.,Elewaut, D.,Haerynck, F.,Dullaers, M.,Adamopoulos, I.E.,Savvides, S.N.
Structural Activation of Pro-inflammatory Human Cytokine IL-23 by Cognate IL-23 Receptor Enables Recruitment of the Shared Receptor IL-12R beta 1.
Immunity, 48:45-58.e6, 2018
Cited by
PubMed: 29287995
DOI: 10.1016/j.immuni.2017.12.008
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.219 Å)
Structure validation

220472

건을2024-05-29부터공개중

PDB statisticsPDBj update infoContact PDBjnumon